New Pharma FCA Settlement Shows Need for Speaker Program Compliance
This Bulletin is brought to you by AHLA’s Fraud and Abuse and Life Sciences Practice Groups.
- February 10, 2025
- Mara Smith Kouba , Bristol Myers Squibb
- Tynan Kugler , PYA
- Jonathan A. Porter , Husch Blackwell LLP
On January 24, 2025, the Justice Department announced a large settlement with a life sciences company (Biohaven Pharmaceutical Holding Company Ltd. or Biohaven) that had recently been purchased by Pfizer, Inc. The settlement was sizable and just one in a string of settlements scrutinizing life sciences speaker programs over the last decade. Yet life sciences companies educating health care providers on the clinical benefits of products is still valuable for all—for the life sciences company, the health care provider, and the providers’ patients—so the critical question is where the line is drawn between government-compliant educational events and non-compliant ones.
ARTICLE TAGS
You must be logged in to access this content.